PRECISE
PRECISE aims to accelerate progress of Portuguese health care toward the new era of precision medicine. Specifically, it will further develop knowledge, instruments and processes to accelerate innovation in technologies for health. It will deliver the prototype of a virtual research platform for Precision Medicine; better clinical decision-making for common immune-mediated diseases; improved diagnosis and treatment of rare immune-mediated diseases; new tools to genotype cancer; more accurate evaluation of molecular pathways altered in cancer; proof-of-principle for novel predictive tools for cancer; improvement in predictive prevention and personalized interventional stroke therapy; better understanding of mitochondrial diseases; improvement in predictive disease modelling; novel processes and best-practices for cell-based innovative medicinal products; improved education on state-of-the-art concepts in precision medicine; and new business ideas for products and services in the field of health and health care.
Project webpage Start year 01/12/2016 End year 31/01/2021 ID SAICTPAC/0021/2015 iBB Role Partner iBB Budget 799 823,18 € Research Group SCERG PI Joaquim Cabral Project Partners IMM- Instituto de Medicina Molecular João Lobo Antunes (Coord.), INESC-ID- Instituto de Engenharia de Sistemas e Computadores: Investigação e Desenvolvimento em Lisboa Status Completed Funding Portugal 2020/FEDER